BioCentury
ARTICLE | Company News

Catabasis Pharmaceuticals, Sarepta Therapeutics deal

October 3, 2016 7:00 AM UTC

The companies partnered to conduct mouse model research to evaluate Duchenne muscular dystrophy (DMD) therapies comprising Sarepta’s exon skipping technology and Exondys 51 eteplirsen analog with Cat...